BioSpace News Archive

Business

RedHill Biopharma’s Talicia® added to Medi-Cal Contract Drug List with No Prior Authorization Requirements

Addition of Talicia® by Medi-Cal Fee-For-Service (FFS) Contract Drug List (CDL) with no prior authorization is an important expansion of coverage for California patients and continues to increase Talicia’s overall unrestricted coverage

October 6, 2021
·
11 min read
Mindset Pharma to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

Mindset Pharma Inc. today announced that James Lanthier , CEO of Mindset, will participate in the KCSA Psychedelics Investor Conference to be held at VirtualInvestorConferences.com on October 13-14, 2021.

October 6, 2021
·
3 min read
Business

Codagenix Announces Appointment of Two New Members to its Board of Directors

Codagenix, Inc. this week announced the appointment of two new members to its Board of Directors each with significant biotechnology and life sciences experience, Lori Rudolph-Owen , Ph.D., and Jill Howe .

October 6, 2021
·
2 min read
Deals

Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.

Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a definitive agreement to acquire Baylis Medical Company Inc. for an upfront payment of $1.75 billion

October 6, 2021
·
6 min read
Genetown

Q-State Biosciences Announces New Therapeutic Programs Targeting Neurodegeneration

Q-State Biosciences today announced a pipeline update introducing three advancing antisense oligonucleotide (ASO) discovery programs targeting rare neurodegenerative disorders.

October 6, 2021
·
2 min read
Genetown

AVROBIO to Present New Clinical and Preclinical Data Across Multiple Programs at the ESGCT 28th Annual Congress

AVROBIO to Present New Clinical and Preclinical Data Across Multiple Programs at the ESGCT 28th Annual Congress

October 6, 2021
·
7 min read
SAB Biotherapeutics to Host Virtual R&D Day on October 13, 2021

SAB Biotherapeutics today announced that it will host a virtual R&D Day on Wednesday, October 13, 2021, at 10:00 a.m. ET

October 6, 2021
·
5 min read
Drug Development

Precirix Dosed First Patients in Phase I/II Clinical Study Evaluating CAM-H2 in HER2-Positive Metastatic Cancer

Precirix NV announces that it has dosed the first patients in its Phase I/II clinical study of CAM-H2 for the treatment of HER2-positive metastatic cancer.

October 6, 2021
·
3 min read
Policy

RedHill Biopharma Ltd Announces Talicia(R) added to Medi-Cal CDL

RedHill Biopharma Ltd. today announced that Medi-Cal has added Talicia® (omeprazole magnesium, amoxicillin and rifabutin)[1] to its Contract Drug List (CDL) for H. pylori treatment, with no prior authorization required, effective October 1, 2021.

October 6, 2021
·
12 min read
Drug Development

AIM ImmunoTech Publishes Phase 1 Clinical Study Data Supporting the Safety of Ampligen as an Intranasal Therapy

AIM ImmunoTech Inc. (NYSE American: AIM) today released detailed safety data from a Phase 1 clinical study which supports the company’s belief that its drug Ampligen has significant potential as an intranasal therapeutic for COVID-19.

October 6, 2021
·
3 min read